Related to Patent Uncertainty and Political Flux Keeping hESC Investors from Seeing Returns

• CIRM Gains Access to Five of BioTime’s ESC Lines
  
• Thomson Reuters and ChemAxon Couple Offerings to Search and Visualize Chemical Patents
  
• Genetic Abnormalities Found in Pluripotent Stem Cell Lines
  
• Animal-Free Culture System for Single-Cell Passaging of hESCs Developed
  
• Lonza and California Stem Cell Introduce MotorPlate Human ESC-Derived Motor Neuron Progenitors
  
• CIT to Distribute Stemina’s hESC-Based Toxicity Assay
  
• Mechanism of How Tet1 Controls Embryonic Stem Cells Revealed
  
• BioTime and XenneX Establish LifeMap to Generate Database of Stem Cell Lineages
  
• 3-D Culturing Prompts ESC Aggregates to Spontaneously Form Optic Cup
  
• Roslin Cellab Adopts Alcohol-Free BioCision's Cryopreservation Tool
  
• Scientists Derive Expandable Neural Progenitor Cells from hESCs and Mouse Embryonic Fibroblasts
  
• Researchers Generate Functional Astrocytes from hESCs and hIPSCs
  
• Scientists Develop Nanoliter System for Prolonged Single-Cell Imaging of ESC Proliferation
  
• Supreme Court Rules Against Stanford in Patent Dispute with Roche over HIV Test
  
• Cell Lineage-Programmed Subsets of hESCs Identified by Surface Markers
  
• Investigators Claim FOXO1 Plays Critical Role in hESC Pluripotency
  
• Scientists Report on Publicly Available Mouse Embryonic Stem Cell miRNA Knockout Resource
  
• Researchers Identify mAbs for Removing Teratoma-Forming Cells from Heterogeneous hESC Populations
  
• BioTime Taps Cornell University Technology for hESC-Derived Vascular Cells
  
• Haploid Mouse ESC Lines Generated For Developmental Studies and Genetic Screening